Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an announcement.
On September 11, 2025, MIRA Pharmaceuticals, Inc. held its Annual Meeting of Shareholders where the 2022 Omnibus Incentive Plan was approved. This plan increases the number of shares reserved from 5,000,000 to 8,000,000 and allows for the repricing of options or stock appreciation rights, potentially impacting the company’s financial strategies and shareholder value.
The most recent analyst rating on (MIRA) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on MIRA Pharmaceuticals, Inc. stock, see the MIRA Stock Forecast page.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,328,501
Technical Sentiment Signal: Strong Buy
For an in-depth examination of MIRA stock, go to TipRanks’ Overview page.